1910 Genetics Funding & Investors
1910 Genetics is a biotechnology company integrating AI, computation, and biological automation to improve drug development. The company establishes an understanding of the molecular basis of disease to the granularity at which the world understands sickle cell anemia. This understanding drives their integration of artificial intelligence (AI), computation, and biological automation to accelerate the design of small molecule and protein therapeutics.
1910genetics.comTotal Amount Raised: $26,650,000
1910 Genetics Funding Rounds
Grant
$550,000
Grant Investors
NINDSSeries A
$22,000,000
Series A Investors
MicrosoftPlayground GlobalSeed
$4,100,000
Seed Investors
Sam AltmanY CombinatorFoundersX VenturesEmles AdvisorsTuck Lye KohScientia Ventures
Funding info provided by Diffbot.